Hims & Hers Health is rated a buy, with a fair value estimate of $41 per share versus the current $29.81. Read more on HIMS ...
Tech Times on MSN
Samsung Galaxy Watch 7 drops to $159 in Prime Big Deal Days: FDA sleep apnea included
Samsung Galaxy Watch 7 deal alert: Amazon dropped the 40mm Bluetooth model to $159 during Prime Big Deal Days, no Prime ...
CI is pairing top AI and biotech minds on its board (plus an advisory role for OpenAI's Fidji Simo) as it tests models on a Novo Nordisk drug.
ClearBridge International Growth ADR Strategy underperformed as its AI infrastructure holdings bore the brunt of the selloff.
Key Stats for Eli Lilly StockPrice change for Eli Lilly stock in last 6 months: 23%$LLY Stock Price as of Oct. 2: $114352-Week High: $1293$LLY Stock Price Target: $1329What Happened?Eli Lilly ...
A new study reveals how lactate-driven lactylation of histone and non-histone proteins in liver cancer activates a ...
A landmark Perspective in Nature Reviews Cancer argues that the cancer dark proteome — thousands of uncharacterized proteins ...
Overseasexpansion can be categorized into three types: integrating models into the core R&D workflow, co-building a wet‑lab ...
Texas against Oklahoma streamed live in 180 degrees on Quest on October 10, with the replay up for seven days. Meta's post ...
"How can we turn peptides that are as effective as injectables into oral drugs?" A clear solution has been proposed for this ...
Saudi Arabia's flagship biotech gathering is no longer a regional talking shop. The Riyadh Global Medical Biotechnology Summit closed its ...
Dave Burke, former Arc Institute CTO and Google Android engineering leader, and Harsh Mehta, Co-Founder and CTO of Mirendil, named AI Advisors NIH Common Fund selects Therna as a Phase I winner of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results